EverSource Wealth Advisors LLC Sells 737 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

EverSource Wealth Advisors LLC decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 15.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 3,910 shares of the financial services provider’s stock after selling 737 shares during the period. EverSource Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $531,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in IBB. Crewe Advisors LLC raised its holdings in shares of iShares Biotechnology ETF by 42.9% during the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock worth $35,000 after acquiring an additional 78 shares during the period. Apexium Financial LP raised its position in iShares Biotechnology ETF by 3.8% in the 4th quarter. Apexium Financial LP now owns 2,223 shares of the financial services provider’s stock valued at $302,000 after buying an additional 82 shares during the last quarter. Jacobi Capital Management LLC lifted its stake in iShares Biotechnology ETF by 3.7% in the 3rd quarter. Jacobi Capital Management LLC now owns 2,539 shares of the financial services provider’s stock valued at $310,000 after acquiring an additional 91 shares in the last quarter. PFG Investments LLC raised its holdings in shares of iShares Biotechnology ETF by 4.8% in the third quarter. PFG Investments LLC now owns 2,013 shares of the financial services provider’s stock valued at $246,000 after purchasing an additional 93 shares during the last quarter. Finally, Huntington National Bank boosted its holdings in iShares Biotechnology ETF by 7.4% during the third quarter. Huntington National Bank now owns 1,450 shares of the financial services provider’s stock worth $177,000 after purchasing an additional 100 shares during the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.9 %

IBB stock traded down $1.27 during midday trading on Thursday, hitting $136.62. The company’s stock had a trading volume of 356,107 shares, compared to its average volume of 1,714,835. The company’s fifty day moving average price is $132.76 and its 200 day moving average price is $131.80. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a $0.126 dividend. The ex-dividend date was Thursday, March 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.37%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.